Filing Details

Accession Number:
0001209191-15-082667
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-01 17:48:04
Reporting Period:
2015-11-27
Filing Date:
2015-12-01
Accepted Time:
2015-12-01 17:48:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1158895 Lemaitre Vascular Inc LMAT Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1365741 R Peter Gebauer C/O Lemaitre Vascular, Inc.
63 Second Avenue
Burlington MA 01803
President, International Op No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-11-27 9,559 $0.10 79,979 No 4 M Direct
Common Stock Disposition 2015-11-27 9,559 $15.86 70,420 No 4 S Direct
Common Stock Acquisiton 2015-11-30 9,901 $0.10 80,321 No 4 M Direct
Common Stock Disposition 2015-11-30 9,901 $15.68 70,420 No 4 S Direct
Common Stock Acquisiton 2015-12-01 17,724 $0.10 88,144 No 4 M Direct
Common Stock Disposition 2015-12-01 17,724 $15.69 70,420 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-11-27 9,559 $0.00 9,559 $0.10
Common Stock Stock Option (Right to Buy) Disposition 2015-11-30 9,901 $0.00 9,901 $0.10
Common Stock Stock Option (Right to Buy) Disposition 2015-12-01 17,724 $0.00 17,724 $0.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
40,441 1997-06-02 2007-06-02 No 4 M Direct
30,540 1997-06-02 2007-06-02 No 4 M Direct
12,816 1997-06-02 2007-06-02 No 4 M Direct
Footnotes
  1. Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
  2. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  3. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $15.64 to $16.12. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
  4. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $15.53 to $15.82. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
  5. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $15.53 to $15.89. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
  6. This option is fully vested and exercisable.
  7. This stock option was originally reported on Form 3 as having an expiration date of June 2, 2007, but does not in fact have an expiration date. Because an expiration date is required to be reported, the originally reported expiration date is included for the sake of consistency.